These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2221854)

  • 1. In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice.
    Piketty C; Derouin F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1467-72. PubMed ID: 2221854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
    Derouin F; Almadany R; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 May; 36(5):997-1001. PubMed ID: 1324642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine.
    Schoondermark-van de Ven E; Galama J; Vree T; Camps W; Baars I; Eskes T; Meuwissen J; Melchers W
    Antimicrob Agents Chemother; 1995 Jan; 39(1):137-44. PubMed ID: 7695295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
    Sina S; Mohammad JM; Reza S; Anita M; Soudabeh E; Hadi M
    Eur J Med Res; 2021 Jun; 26(1):65. PubMed ID: 34193287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
    de Diego JA; Penin P; Arribas JR; Vázquez E; Vázquez JJ
    Folia Microbiol (Praha); 1996; 41(6):513-6. PubMed ID: 9131805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii.
    Gross U; Pohl F
    Curr Top Microbiol Immunol; 1996; 219():235-45. PubMed ID: 8791704
    [No Abstract]   [Full Text] [Related]  

  • 11. Rifabutin is active in murine models of toxoplasmosis.
    Araujo FG; Slifer T; Remington JS
    Antimicrob Agents Chemother; 1994 Mar; 38(3):570-5. PubMed ID: 8203856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parasitemia and parasitic loads in acute infection and after anti-gamma-interferon treatment in a toxoplasmic mouse model.
    Miédougé M; Bessières MH; Cassaing S; Swierczynski B; Séguéla JP
    Parasitol Res; 1997; 83(4):339-44. PubMed ID: 9134554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii: blood and tissue kinetics during acute and chronic infections in mice.
    Derouin F; Garin YJ
    Exp Parasitol; 1991 Nov; 73(4):460-8. PubMed ID: 1959573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.
    Derouin F; Piketty C; Chastang C; Chau F; Rouveix B; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Feb; 35(2):252-5. PubMed ID: 2024957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoccidial activity of 2-sulfamoyl-4,4-diaminodiphenylsulfone, sulfadiazine, pyrimethamine and clindamycin in cats infected with Toxoplasma gondii.
    Dubey JP; Yeary RA
    Can Vet J; 1977 Mar; 18(3):51-7. PubMed ID: 858118
    [No Abstract]   [Full Text] [Related]  

  • 17. The activity of atovaquone (566C80) in murine toxoplasmosis is markedly augmented when used in combination with pyrimethamine or sulfadiazine.
    Araujo FG; Lin T; Remington JS
    J Infect Dis; 1993 Feb; 167(2):494-7. PubMed ID: 8421189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
    Romand S; Della Bruna C; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis and treatment of congenital Toxoplasma gondii infections: an experimental study in rhesus monkeys.
    Schoondermark-van de Ven EM; Melchers WJ; Galama JM; Meuwissen JH; Eskes TK
    Eur J Obstet Gynecol Reprod Biol; 1997 Aug; 74(2):183-8. PubMed ID: 9306115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.